Pulse Biosciences presenterar ablationsteknik på sjukvårdskonferens

Pulse Biosciences redogjorde för sina framsteg inom nanosekundbaserad pulsfältsablation under en presentation vid Bank of America Global Healthcare Conference den 13 maj.

VD Paul LaViolette talade inför deltagarna tillsammans med moderatorn Dan Lundquist. Han beskrev företagets exklusiva fokus på nanosekundbaserad pulsfältsablation, som utlöser reglerad celldöd genom en ny energimekanism. LaViolette betonade pågående kliniska prövningar och strävan efter att nå stora patientgrupper på flera ablationsmarknader.

Relaterade artiklar

3D cryo-expansion microscopy image of a killer T cell's immune synapse with a tumor cell, revealing nanoscale killing machinery organization.
Bild genererad av AI

Cryo-expansion microscopy captures 3D architecture of killer T cells at the immune synapse, including in human tumors

Rapporterad av AI Bild genererad av AI Faktagranskad

Researchers from the University of Geneva and Lausanne University Hospital report they have visualized, in three dimensions and under near-native conditions, how cytotoxic T cells organize their killing machinery at the immune synapse. The work, published in Cell Reports, applies cryo-expansion microscopy to human T cells and to tumor tissue samples, providing nanoscale views intended to support immunology and cancer research.

Sutro Biopharma, Inc. presented at the 16th Annual World ADC London Summit on February 28, 2026. The company published a slide deck in conjunction with the event.

Rapporterad av AI

Scientists at Scripps Research have developed a nanodisc platform that mimics viral membranes, uncovering hidden interactions in HIV and Ebola proteins that traditional methods miss. The technology allows for more accurate study of antibody responses, potentially accelerating vaccine development. The findings appear in Nature Communications.

Researchers at Helmholtz-Zentrum Dresden-Rossendorf have filmed copper atoms losing and regaining electrons in femtoseconds using dual lasers. The experiment creates superheated plasma mimicking extreme cosmic conditions. Findings could advance laser fusion research.

Rapporterad av AI

AbCellera Biologics Inc. has released a slide deck related to its fourth-quarter 2025 results. The presentation accompanies the company's earnings call. It was published on February 24, 2026.

Denna webbplats använder cookies

Vi använder cookies för analys för att förbättra vår webbplats. Läs vår integritetspolicy för mer information.
Avböj